Personalized Medicine Progresses
Notable breakthroughs in personalized medicine continue, but reimbursement hurdles and regulation concerns have posed occasional setbacks.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Dementias & Alzheimer’s, Heart Disease, Molecular Diagnostics |
Notable breakthroughs in personalized medicine continue, but reimbursement hurdles and regulation concerns have posed occasional setbacks.
Read MorePosted by Steve Halasey | May 12, 2014 | Research |
Investigators at the Johns Hopkins Kimmel Cancer Center have designed a blood test that accurately detects the presence of advanced breast cancer and also holds promise for precisely monitoring response to cancer treatment.
Read MorePosted by Jenny Lower | May 1, 2014 | Swabs, Uncategorized |
New products include high-throughput biobanking tubes from Greiner Bio-One, a centrifuge rotor from Beckman Coulter, and color-coded microbial test films from Neogen Corp.
Read MorePosted by Jenny Lower | Apr 24, 2014 | Molecular Diagnostics |
The Protecting Access to Medicare Act of 2014 incorporates fundamental changes to the way that the Centers for Medicare & Medicaid Services will handle future coding and payment issues for lab testing. To understand the ongoing reimbursement concerns of molecular pathologists, CLP visited with Mary Steele Williams, executive director of the Association for Molecular Pathology.
Read MorePosted by Steve Halasey | Apr 11, 2014 | Cancer |
CDC’s grant of more than $1.25 million to the College of American Pathologists will help laboratory professionals improve the delivery of patient testing guidelines and cancer reporting.
Read More